Kiromic Biopharma Kiromic BioPharma (formerly known as Kiromic) is a target discovery and gene editing company focusing on developing immuno-oncology therapeutics for the treatment of blood cancers and solid tumors. | ![]() Dragonfly Dragonfly Therapeutics is a company developing drugs targeted at natural killer cells and other cells of the body's innate immune system to eliminate cancer. | ||
Founding Date | Founding Date 2001 | Founding Date 2012 | Founding Date 2015 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Lund, SE HQ | Locations Houston, US HQ | Locations Waltham, US HQ |
Employees | Employees 1555% decrease | Employees 4426% increase | Employees 109 |
Valuation ($) | Valuation ($) 59 m | Valuation ($) 1.8 m | Valuation ($) N/A |
Financial | |||
Net income | Net income (kr51.4m) (FY, 2025) | Net income ($26.9m) (FY, 2024) | Net income N/A |
Kiromic BioPharma (formerly known as Kiromic) is a target discovery and gene editing company focusing on developing immuno-oncology therapeutics for the treatment of blood cancers and solid tumors.
View company
Dragonfly Therapeutics is a company developing drugs targeted at natural killer cells and other cells of the body's innate immune system to eliminate cancer.
View company